Bacterial etiology of chronic bronchitis exacerbations treated by primary care physicians;Etiología bacteriana de la agudización de la bronquitis crónica en atención primaria

Archivos de Bronconeumologia

Volumn 42, Issue 8, 2006, Pages 388-393

  Llor, Carles ^a,e   Cots, Josep Maria ^b,c   Herreras, Amadeo ^d  

^a Centro de Salud Jaume I   (Spain)

^b Centro de Salud La Marina   (Spain)

^c Sociedad Española de Medicina de Familia

^d Centro de Investigation Basica Sanofi Aventis   (Spain)

^e NONE   (Spain)

Author keywords

Acute exacerbation; Bronchitis, chronic; Etiology

Indexed keywords

AMOXICILLIN; MACROLIDE;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CHRONIC BRONCHITIS; CLINICAL TRIAL; GRAM STAINING; HAEMOPHILUS INFLUENZAE TYPE A; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MICROSCOPY; MORAXELLA CATARRHALIS; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSICIAN; PRIMARY MEDICAL CARE; SPUTUM ANALYSIS; STREPTOCOCCUS PNEUMONIAE;

EID: 33748769787     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13091647     Document Type: Article

References (37)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease study. Lancet. 1997;349:1498-504.
2. Mannino DM. COPD. Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121 Suppl 5: 121S-6.
3. Hirschmann JV. Do bacteria cause exacerbations of COPD? Chest. 2000;118:193-203.
4. White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease. 6: The aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax. 2003;58:73-80.
5. Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003;58:37-42.
6. Monsó E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J, et al. Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med. 1995;152:1316-20.
7. Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest. 2002;121 5 Suppl:136-41.
8. Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest. 1998;113:1542-8.
9. Miravitlles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M, and Study Group of Bacterial Infection in COPD. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest. 1999;116:40-6.
10. Miravitlles M, Mayordomo C, Artés M, Sánchez-Agudo L, Nicolau F, Segú JL. Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. Respir Med. 1999;93:173-9.
11. Pérez-Trallero E, García de la Fuente C, García-Rey C, Baquero F, Aguilar L, Dal-Re R, et al; Spanish Surveillance Group for Respiratory Pathogens. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother. 2005;49:1965-72.
12. Picazo JJ, Betriu C, Rodríguez-Avial I, Culebras E, Gómez M; Grupo VIRA. Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2004. Enferm Infecc Microbiol Clin. 2004;22:517-25.
13. American Thoracic Society. Definition and classification of chronic bronchitis, asthma, and pulmonary emphysema. Am Res Resp Dis. 1962;85:762-8.
14. Murray PR, Washington JA. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc. 1975;50:339-44.
15. Heineman HS, Chawla JK, Lofton WM. Misinformation from sputum cultures without microscopic examination. J Clin Microbiol. 1977;6:518-27.
16. Anthonisen, NR, Manfreda, J, Warren CP, Warren CP, Herschfield ES, Harding GK, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106:196-204.
17. Lieberman D, Shmarkov O, Gelfer Y, Varsavsky R, Lieberman DV. Prevalence and clinical significance of fever in acute exacerbations of chronic obstructive pulmonary disease. Eur J Clin Microbiol Infect Dis. 2003;22:75-8.
18. Murphy TF, Sethi S. Bacterial infection in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;146:1067-83.
19. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000;109:288-95.
20. Davies L, Hadcroft J, Mutton K, Earis JE, Kennedy N. Antimicrobial management of acute exacerbation of chronic airflow limitation. Q J Med. 2001;94:373-8.
21. Soler N, Torres A, Ewig S, Gonzalez J, Celis R, El-Ebiary M, et al Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med. 1998;157:1498-505.
22. Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347:465-71.
23. Crooks SW, Bayley DL, Hill SL, Stockley RA. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4. Eur Respir J. 2000;15:274-80
24. Monsó E. Colonización bronquial en la enfermedad pulmonar obstructiva crónica: algo se esconde debajo de la alfombra. Arch Bronconeumol. 2004;40:543-6.
25. Rosell A, Monsó E, Soler N, Torres F, Angrill J, Riise G, et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med. 2005;165:891-7.
26. Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57:759-64.
27. Miravitlles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M, et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest. 1999;116:40-6.
28. Viejo JL, Fernández MA, Laparra J. Estudio epidemiológico de los agentes patógenos hallados en las agudizaciones de la bronquitis crónica en el norte de España. Arch Bronconeumol. 1997;33:106.
29. Mobbs KJ, Van Saene HK, Sunderland D, Davies PD. Oropharyngeal Gram-negative bacillary carriage in chronic obstructive pulmonary disease: relation to severity of disease. Respir Med. 1999;93:540-5.
30. Zalacaín R, Sobradillo V, Amilibia J, Barrón J, Anchólegui V, Pijoan JI, et al. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J. 1999;13:343-8.
31. Monso E, Rosell A, Bonet G, Manterola J, Cardona PJ, Ruiz J, et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J. 1999;13:338-42.
32. Sethi S. Infectious etiology of acute exacerbations of chronic bronchitis. Chest. 2000;117:380S-5S.
33. Llor C, Naberan K, Cots JM, Molina J, Miravitlles M. Economic evaluation of the antibiotic treatment of exacerbations of chronic bronchitis and COPD in primary care centers. Int J Clin Pract. 2004;58:937-44.
34. Ruiz J. Tratamiento de la infecciön en la exacerbación de la enfermedad pulmonar obstructiva crónica. Revisión de las guías internacionales y nacionales. Arch Bronconeumol. 2004;40:26-9.
35. Álvarez F, Bouza E, García-Rodríguez JA, Mensa J, Monso E, Picazo JJ, et al. Segundo documento de consenso sobre uso de anti-microbianos en la exacerbación de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2003;39:274-82.
36. Grupo de trabajo de la Asociación Latinoamericana del Tórax (ALAT). Actualización de las recomendaciones ALAT sobre la exacerbación infecciosa de la EPOC. Arch Bronconeumol. 2004;40:315-25.
37. a ed. Sant Carles: Dassoy; 2005. p. 35-51.